Carnosic acid suppresses colon tumor formation in association with antiadipogenic activity

Mol Nutr Food Res. 2014 Dec;58(12):2274-85. doi: 10.1002/mnfr.201400293. Epub 2014 Oct 9.

Abstract

Scope: This study determined the efficacy of carnosic acid (CA) for suppressing colon carcinogenesis associated with excess adiposity.

Methods and results: Cell growth regulation by CA was evaluated in HT-29 colon adenocarcinoma cells cocultured with 3T3-L1 adipocytes. To determine the in vivo efficacies, male A/J mice were divided into four groups and fed one of the following experimental diets for 11 wk: 15% fat, 45% fat, 45% fat + 0.01% CA, or 45% fat + 0.02% CA. Azoxymethane was administered at the beginning of experimental diet and two cycles of dextran sodium sulfate were supplied 1 wk after the azoxymethane injection. The proliferation of HT-29 cells cocultured with 3T3-L1 cells was significantly higher than proliferation of control cells (p < 0.05). CA treatment suppressed the growth of cocultured HT-29 cells through cell cycle arrest and enhanced apoptosis by inhibiting leptin receptor (Ob-R) signaling, including Akt and extracellular signal-regulated kinase (ERK) phosphorylation. CA supplementation in vivo decreased the number of colon tumors and reduced circulating concentrations of leptin, adiponectin, insulin, and insulin-like growth factor 1. Colonic expression of Ob-R, insulin receptor (IR), p-Akt, p-ERK, B-cell lymphoma extra large (Bcl-xL), and cyclinD1 protein was also suppressed in animals fed CA.

Conclusion: CA appears to alleviate adipocity-related acceleration of colon tumor formation.

Keywords: Carnosic acid; Colitis; Colon cancer; Obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Abietanes / pharmacology*
  • Adipocytes / drug effects
  • Adipogenesis / drug effects*
  • Adiponectin / blood
  • Adiposity / drug effects
  • Animals
  • Apoptosis / drug effects
  • Azoxymethane / adverse effects
  • Cell Proliferation / drug effects
  • Colon / drug effects
  • Colon / metabolism
  • Colonic Neoplasms / drug therapy*
  • Cyclin D1 / genetics
  • Cyclin D1 / metabolism
  • Dextran Sulfate / adverse effects
  • Extracellular Signal-Regulated MAP Kinases / genetics
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • HT29 Cells
  • Humans
  • Insulin / blood
  • Insulin-Like Growth Factor I / metabolism
  • Interleukin-6 / metabolism
  • Leptin / blood
  • Male
  • Mice
  • Plant Extracts / pharmacology*
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor, Insulin / metabolism
  • Receptors, Leptin / metabolism
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism

Substances

  • Abietanes
  • Adiponectin
  • Bcl2l1 protein, mouse
  • Ccnd1 protein, mouse
  • Insulin
  • Interleukin-6
  • Leptin
  • Plant Extracts
  • Receptors, Leptin
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • bcl-X Protein
  • leptin receptor, mouse
  • Cyclin D1
  • Insulin-Like Growth Factor I
  • Dextran Sulfate
  • Receptor, Insulin
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • salvin
  • Azoxymethane